Cargando…
Reduced biophotonic activities and spectral blueshift in Alzheimer’s disease and vascular dementia models with cognitive impairment
BACKGROUND: Although clinically, Alzheimer’s disease (AD) and vascular dementia (VaD) are the two major types of dementia, it is unclear whether the biophotonic activities associated with cognitive impairments in these diseases share common pathological features. METHODS: We used the ultraweak bioph...
Autores principales: | Wang, Zhuo, Xu, Zhipeng, Luo, Yi, Peng, Sisi, Song, Hao, Li, Tian, Zheng, Jiaxin, Liu, Na, Wu, Shenjia, Zhang, Junxia, Zhang, Lei, Hu, Yuan, Liu, Yanping, Lu, Dongwei, Dai, Jiapei, Zhang, Junjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505668/ https://www.ncbi.nlm.nih.gov/pubmed/37727319 http://dx.doi.org/10.3389/fnagi.2023.1208274 |
Ejemplares similares
-
Gout and risk of dementia, Alzheimer's disease or vascular dementia: a meta-epidemiology study
por: Li, Xuanlin, et al.
Publicado: (2023) -
Origin of the blueshift of photoluminescence in a type-II heterostructure
por: Jo, Masafumi, et al.
Publicado: (2012) -
Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia
por: Gan, Jinghuan, et al.
Publicado: (2023) -
Neuropsychological differential diagnosis of Alzheimer’s disease and vascular dementia: a systematic review with meta-regressions
por: Sokolovič, Leo, et al.
Publicado: (2023) -
Origin of the blueshift of water molecules at interfaces of hydrophilic cyclic compounds
por: Tomobe, Katsufumi, et al.
Publicado: (2017)